ARASH KARDAN to Radiopharmaceuticals
This is a "connection" page, showing publications ARASH KARDAN has written about Radiopharmaceuticals.
Connection Strength
0.288
-
(111)In WBC SPECT/CT detection of a radiographically occult solitary infected renal cyst in polycystic kidney disease. Clin Nucl Med. 2015 Jun; 40(6):542-4.
Score: 0.117
-
18F-FDG PET/CT in a 16-year-old patient with hydranencephaly. Clin Nucl Med. 2014 Oct; 39(10):e445-7.
Score: 0.112
-
Pilot pharmacokinetic and dosimetric studies of (18)F-FPPRGD2: a PET radiopharmaceutical agent for imaging a(v)?(3) integrin levels. Radiology. 2011 Jul; 260(1):182-91.
Score: 0.022
-
Reproducibility and accuracy of quantitative myocardial blood flow assessment with (82)Rb PET: comparison with (13)N-ammonia PET. J Nucl Med. 2009 Jul; 50(7):1062-71.
Score: 0.019
-
Delayed heart rate recovery after adenosine stress testing with supplemental arm exercise predicts mortality. J Nucl Cardiol. 2009 Jan-Feb; 16(1):54-62.
Score: 0.019